Schmidt A W, Peroutka S J
Department of Neurology, Stanford University, California 94305.
FASEB J. 1989 Sep;3(11):2242-9. doi: 10.1096/fasebj.3.11.2673898.
The identification of multiple receptor subtypes for 5-hydroxytryptamine (5-HT) made by using radioligand binding techniques proliferated at a brisk rate in the 1980s. The application of molecular biological techniques to 5-HT receptor studies is likely to lead to an expansion rather than a reduction in the number of distinct 5-HT receptor subtypes. Although the current status of 5-HT receptor pharmacology may appear to be overwhelmingly confusing to most investigators, the evolving data suggest that 5-HT receptor subtypes can be categorized into three major families. Each family consists of multiple receptor subtypes that share similarities in their molecular biological, pharmacological, biochemical, and/or physiological properties. This review provides a summary of recent data as well as a framework for the classification of 5-HT receptor subtypes.
20世纪80年代,运用放射性配体结合技术对5-羟色胺(5-HT)多种受体亚型的鉴定迅速发展。将分子生物学技术应用于5-HT受体研究,可能会使不同5-HT受体亚型的数量增加而非减少。尽管目前5-HT受体药理学的状况对大多数研究者来说可能极其令人困惑,但不断发展的数据表明,5-HT受体亚型可分为三大类。每个类别都由多个受体亚型组成,它们在分子生物学、药理学、生物化学和/或生理学特性上具有相似性。本综述总结了近期数据,并为5-HT受体亚型的分类提供了一个框架。